ATE71657T1 - Protein-a material und dessen herstellung. - Google Patents

Protein-a material und dessen herstellung.

Info

Publication number
ATE71657T1
ATE71657T1 AT83306500T AT83306500T ATE71657T1 AT E71657 T1 ATE71657 T1 AT E71657T1 AT 83306500 T AT83306500 T AT 83306500T AT 83306500 T AT83306500 T AT 83306500T AT E71657 T1 ATE71657 T1 AT E71657T1
Authority
AT
Austria
Prior art keywords
protein
cloning
nucleotide sequence
manufacture
gene
Prior art date
Application number
AT83306500T
Other languages
English (en)
Inventor
Donald A Colbert
Algis Anilionis
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Application granted granted Critical
Publication of ATE71657T1 publication Critical patent/ATE71657T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT83306500T 1982-10-27 1983-10-26 Protein-a material und dessen herstellung. ATE71657T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/436,955 US5151350A (en) 1982-10-27 1982-10-27 Cloned genes encoding recombinant protein a
EP83306500A EP0107509B1 (de) 1982-10-27 1983-10-26 Protein-A Material und dessen Herstellung

Publications (1)

Publication Number Publication Date
ATE71657T1 true ATE71657T1 (de) 1992-02-15

Family

ID=23734479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83306500T ATE71657T1 (de) 1982-10-27 1983-10-26 Protein-a material und dessen herstellung.

Country Status (6)

Country Link
US (1) US5151350A (de)
EP (1) EP0107509B1 (de)
JP (2) JPH0811068B2 (de)
AT (1) ATE71657T1 (de)
CA (1) CA1307483C (de)
DE (1) DE3382495D1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
US4691009A (en) * 1984-12-26 1987-09-01 Repligen Corporation Hybrid proteins produced by an ultrahigh prokaryotic expression system
SE459503B (sv) * 1985-05-03 1989-07-10 Excorim Kommanditbolag Hybrid-dna-molekyl innefattande dna-sekvens som kodar foer protein g samt foerfarande foer framstaellning av protein g
DK528285D0 (da) * 1985-11-15 1985-11-15 Novo Industri As Peptider samt praeparater indeholdende disse
EP0234592A1 (de) * 1986-02-28 1987-09-02 Teijin Limited Plasmid, das ein DNA-Fragment enthält, welches für die Fc-Region von menschlichem Immunoglobulin G Protein codiert, und Verwendung desselben zur Herstellung des genannten Proteins
SE459662B (sv) * 1986-03-21 1989-07-24 Pharmacia Ab Hybrid-dna-molekyl som kodar foer ett protein med samma igg specificitet som protein g, plasmid innehaallande densamma samt foerfarande foer framstaellning av proteinet
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
JPS6348297A (ja) * 1986-08-18 1988-02-29 Sanraku Inc Ｆｃ結合性蛋白質及びその生産菌
EP0289129A3 (de) * 1987-03-26 1990-10-10 Repligen Corporation Herstellung von hochgereinigtem Protein A
US5084559A (en) * 1987-03-27 1992-01-28 Repligen Corporation Protein a domain mutants
US5084398A (en) * 1987-11-20 1992-01-28 Creative Biomolecules Selective removal of immune complexes
DE3887750T2 (de) * 1987-11-20 1994-09-15 Creative Biomolecules Inc Selektive entfernung von immunkomplexen.
US5243040A (en) * 1987-11-20 1993-09-07 Creative Biomolecules DNA encoding a protein which enables selective removal of immune complexes
DE68907388T2 (de) * 1988-07-22 1994-01-05 Imre Corp Gereinigte Protein A-Zusammensetzungen und Verfahren zu ihrer Herstellung.
JP2871709B2 (ja) * 1988-11-21 1999-03-17 住友製薬株式会社 免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法
JPH02308791A (ja) * 1989-05-24 1990-12-21 Sekisui Chem Co Ltd 免疫グロブリンＦｃ領域に対する結合能力とルシフェラーゼ活性をもつポリペプチド
GB9013872D0 (en) * 1990-06-21 1990-08-15 Inst Tecnologico Y Cientifico Use of protein a and polypeptide components thereof in the treatment of tumours
CA2096953A1 (en) * 1990-11-26 1992-05-27 Anthony Atkinson Immunoglobulin-binding proteins and recombinant dna molecules coding therefor
JP2519136B2 (ja) * 1991-07-25 1996-07-31 オリエンタル酵母工業株式会社 分子量マ−カ−
JP2584697B2 (ja) * 1991-08-23 1997-02-26 オリエンタル酵母工業株式会社 ＩｇＧ精製用組換え型プロテインＡ
EP0550771B1 (de) * 1991-07-25 1999-09-29 Oriental Yeast Co., Ltd. Künstliches immunoglobulin-bindendes protein
GB9526356D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel compounds
US6001600A (en) * 1996-12-20 1999-12-14 Smithkline Beecham Plc DNA encoding tests polypeptides
GB9526359D0 (en) * 1995-12-22 1996-02-21 Smithkline Beecham Plc Novel compounds
GB9600955D0 (en) * 1996-01-17 1996-03-20 Smithkline Beecham Plc Novel compounds
US7432365B1 (en) 1998-01-27 2008-10-07 O'donnell Michael E DNA molecules encoding beta clamp proteins of gram positive bacteria
WO1999037661A1 (en) * 1998-01-27 1999-07-29 The Rockefeller University Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
AU6749900A (en) * 1999-07-29 2001-02-19 Rockefeller University, The Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
US7098383B2 (en) * 2000-12-19 2006-08-29 Sembiosys Genetics Inc. Methods for the production of multimeric immunoglobulins, and related compositions
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
BR0116220A (pt) * 2000-12-19 2003-09-23 Sembiosys Genetics Inc Métodos para a produção de proteìnas multiméricas e composições relacionadas
US20090137416A1 (en) 2001-01-16 2009-05-28 Regeneron Pharmaceuticals, Inc. Isolating Cells Expressing Secreted Proteins
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
JP2005112827A (ja) * 2003-10-10 2005-04-28 National Institute Of Advanced Industrial & Technology 抗体アフィニティ担体
SE0400501D0 (sv) * 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
CA2552639C (en) * 2004-02-27 2012-05-01 Ge Healthcare Bio-Sciences Ab A process for the purification of antibodies
EP1767640A4 (de) 2004-07-06 2008-03-26 Kaneka Corp Verfahren zur herstellung eines protein-a-ähnlichen proteins unter verwendung eines bakteriums der gattung brevibacillus
EP1774017B1 (de) 2004-07-26 2013-05-15 Pfenex Inc. Verfahren zur verbesserten proteinexpression durch strain-engineering
BRPI0518216C8 (pt) 2004-10-21 2017-03-21 Ge Healthcare Bio Sciences Ab ligante de cromatografia, métodos de preparação de uma matriz de separação, e de separação de um ou mais anticorpos de um ou mais outros compostos em uma amostra líquida, matriz de separação, e, coluna de cromatografia descartável.
US8728828B2 (en) 2004-12-22 2014-05-20 Ge Healthcare Bio-Sciences Ab Purification of immunoglobulins
EP1746103A1 (de) 2005-07-20 2007-01-24 Applied NanoSystems B.V. Bifunktionelle Protein-Anker
US7375188B2 (en) * 2005-07-29 2008-05-20 Mallinckrodt Baker, Inc. Vegetarian protein a preparation and methods thereof
CA2664530C (en) 2006-09-29 2015-11-17 Ge Healthcare Bio-Sciences Ab Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation
EP2099932A4 (de) * 2006-12-06 2009-11-18 Repligen Corp Nukleinsäuren zur kodierung des rekombinanten proteins a
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9394571B2 (en) 2007-04-27 2016-07-19 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US8828905B2 (en) * 2007-05-30 2014-09-09 Kaneka Corporation Porous base matrix having formyl group, adsorbent using the porous base matrix, method for production of the porous base matrix, and method for production of the adsorbent
SG149759A1 (en) * 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
ES2391931T3 (es) * 2008-09-15 2012-12-03 Emd Millipore Corporation Procedimientos para cuantificar la filtración de proteína desde resinas de cromatografía de afinidad basada en proteína
EP2339339A4 (de) 2008-09-25 2016-10-12 Jsr Corp Füllmittel für affinitätschromatographie
CN103816870B (zh) 2008-12-03 2016-11-23 株式会社钟化 含有甲酰基的多孔性载体、使用该多孔性载体的吸附体以及它们的制造方法
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
EP3281947B1 (de) 2009-04-03 2020-02-12 The University of Chicago Zusammensetzungen und verfahren in verbindung mit protein-a (spa)-varianten
EP2562178B1 (de) 2010-03-31 2015-05-06 JSR Corporation Füllmittel für affinitätschromatographie
ES2655701T3 (es) 2010-07-02 2018-02-21 The University Of Chicago Composiciones y métodos relacionados con variantes de la proteína A (SpA)
WO2012124145A1 (ja) 2011-03-15 2012-09-20 オムロン株式会社 演算ユニット、支援装置、支援プログラム、支援プログラムを格納した記憶媒体、および、支援装置における動作方法
SG10201604559TA (en) 2011-06-08 2016-07-28 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
WO2014038686A1 (ja) 2012-09-10 2014-03-13 株式会社カネカ 吸着体
IN2015DN02055A (de) 2012-09-17 2015-08-14 Grace W R & Co
TW202423993A (zh) * 2012-11-14 2024-06-16 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
EP3059251B1 (de) 2013-10-15 2019-04-03 Kaneka Corporation Verfahren zur herstellung von porösen celluloseperlen
US10040053B2 (en) 2013-10-15 2018-08-07 Kaneka Corporation Production method for porous cellulose beads, and adsorbent employing same
US10189007B2 (en) 2013-10-15 2019-01-29 Kaneka Corporation Method for producing porous cellulose beads and adsorbent employing same
EP3094390B1 (de) 2014-01-16 2021-07-07 W.R. Grace & CO. - CONN. Affinitätschromatographiemedien und chromatographievorrichtungen
US20240100450A9 (en) * 2014-01-17 2024-03-28 Repligen Corporation Sterilizing chromatography columns
WO2015109246A1 (en) * 2014-01-17 2015-07-23 Repligen Corporation Sterilizing chromatography columns
EP3137209B1 (de) 2014-05-02 2022-10-05 W.R. Grace & CO. - CONN. Funktionalisiertes trägermaterial und verfahren zur herstellung und verwendung eines funktionalisierten trägermaterials
SG10201911134QA (en) 2015-06-05 2020-01-30 Grace W R & Co Adsorbent bioprocessing clarification agents and methods of making and using the same
US11884705B2 (en) 2017-09-25 2024-01-30 Jsr Corporation Immunoglobulin binding protein, and affinity support using same
WO2019059399A1 (ja) 2017-09-25 2019-03-28 Jsr株式会社 イムノグロブリン結合タンパク質、及びそれを用いたアフィニティー担体
WO2019244961A1 (ja) 2018-06-20 2019-12-26 Jsr株式会社 変異ｖｈｈ抗体を用いたアフィニティー担体
WO2020040307A1 (ja) 2018-08-24 2020-02-27 Jsr株式会社 イムノグロブリン結合タンパク質、及びそれを用いたアフィニティー担体
AU2020273471B2 (en) 2019-05-14 2026-05-07 The University Of Chicago Methods and compositions comprising Staphylococcus protein A (SpA) variants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293652A (en) * 1979-05-25 1981-10-06 Cetus Corporation Method for synthesizing DNA sequentially
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US4322274A (en) * 1980-08-28 1982-03-30 Wilson Gregory B Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
SE8204810L (sv) * 1982-08-23 1984-02-24 Pharmacia Fine Chemicals Ab Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
SE8204811L (sv) * 1982-08-23 1984-02-24 Sven Lofdahl Dna-fragment innefattande en signalsekvens
DE3314812A1 (de) * 1983-04-23 1984-10-25 Battelle-Institut E.V., 6000 Frankfurt Mittel zum antigen/antikoerper-nachweis
US4617266A (en) * 1983-04-28 1986-10-14 Genex Corporation Production of Protein A

Also Published As

Publication number Publication date
JPH08107795A (ja) 1996-04-30
EP0107509B1 (de) 1992-01-15
US5151350A (en) 1992-09-29
JPS59113890A (ja) 1984-06-30
EP0107509A2 (de) 1984-05-02
CA1307483C (en) 1992-09-15
JPH0811068B2 (ja) 1996-02-07
DE3382495D1 (de) 1992-02-27
EP0107509A3 (en) 1986-03-26

Similar Documents

Publication Publication Date Title
DE3382495D1 (de) Protein-a material und dessen herstellung.
Murphy et al. SP-40, 40 is an inhibitor of C5b-6-initiated haemolysis
ATE143052T1 (de) Chimärisches murine-mensch-immunoglobulin, spezifisch für tumorassoziertes 17-1a antigen
DK0492448T3 (da) Monoklonale antistoffer mod human tumor-nekrotiserende faktor alfa
DE69023900D1 (de) Gentechnologisch veränderte immunglobuline.
HUP0102535A2 (hu) Új CD 19xCD3 specifikus polipeptidek és alkalmazásuk
DE3588219D1 (de) T-Zellenrezeptor, spezifisch für Antigenpolypeptide und verwandte Polynukleotide
MY108519A (en) Novel antibodies reactive with human carcinomas.
DE69638355D1 (de) Anti-CD3-Antikörper zur Verwendung zur Induzierung von Immunsuppression
DE58909458D1 (de) Antigenkonstrukte von "Major Histocompatibility Complex" Klasse I Antigenen mit spezifischen Trägermolekülen, ihre Herstellung und Verwendung.
ES8607564A1 (es) Un metodo para determinar la presencia de un determinante antigenico de interleuquina-2-en una muestra.
ES8706964A1 (es) Un procedimiento para fraccionar anticuerpos de suero.
DK113389D0 (da) Monoklonale antistoffer
DE3485559D1 (de) Anti-protein c monoklonaler antikoerper, seine herstellung und verwendung.
Weir et al. Comparison of the structure of the immunoglobulins from horse serum
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
Sharon et al. Association constants of hybridoma antibodies specific for α (1→ 6) linked dextran determined by affinity electrophoresis
TW272197B (de)
ES8607024A1 (es) Anticuerpos monoclonales
DE69033220D1 (de) Immunoassays für und monoklonale antikörper gegen prothrombin-aktivierende peptide und ihre abbauprodukte
KR900701318A (ko) 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체
DE69529272D1 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
ATE180489T1 (de) Für leberzellkarzinom spezifisches onkogen
DK0454782T3 (da) Cancer-beslægtet haptaglobin (Hpr.)
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time